Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

Historical Holders from Q3 2019 to Q1 2025

Symbol
MIRM on Nasdaq
CUSIP
604749101
Type / Class
Equity / Common Stock
Shares outstanding
48.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
53M
Holdings value
$2.19B
% of all portfolios
0.006%
Grand Portfolio weight change
0%
Number of holders
202
Number of buys
105
Number of sells
-72
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 9.5% $206M 4.58M JANUS HENDERSON GROUP PLC Dec 31, 2024
EVENTIDE ASSET MANAGEMENT, LLC 5.43% $117M 2.61M Eventide Asset Management, LLC Dec 31, 2024

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 291K $13.1M +$1.08M $45.05 13
2024 Q4 53M $2.19B -$15.5M $41.35 202
2024 Q3 53.1M $2.07B -$12.7M $39.00 178
2024 Q2 53.4M $1.82B +$11.9M $34.19 160
2024 Q1 53.2M $1.34B +$67.5M $25.12 169
2023 Q4 50M $1.48B -$24.4M $29.52 183
2023 Q3 48.7M $1.54B +$387M $31.60 157
2023 Q2 36.9M $956M +$63.1M $25.87 143
2023 Q1 34.7M $833M +$34M $24.02 114
2022 Q4 33.3M $650M -$11.8M $19.50 101
2022 Q3 32M $672M +$84.2M $21.01 105
2022 Q2 29.1M $565M +$45.7M $19.46 100
2022 Q1 26.8M $590M +$50.8M $22.02 98
2021 Q4 24.8M $395M +$18.7M $15.95 80
2021 Q3 21.4M $426M +$2.76M $19.92 69
2021 Q2 21.5M $371M +$679K $17.29 65
2021 Q1 23.4M $425M -$8.43M $19.82 61
2020 Q4 22M $384M +$52.3M $17.46 71
2020 Q3 18.7M $361M -$1.29M $19.27 50
2020 Q2 18.8M $366M +$8.88M $19.46 56
2020 Q1 18.6M $260M +$32.1M $14.00 43
2019 Q4 16.2M $398M +$12.8M $24.52 39
2019 Q3 16.5M $166M +$166M $10.06 37